Gary Jacob’s rise to CEO of a Nasdaq-listed biotech company started with chemistry classes in Benton Hall and a willingness to take risks and embrace change.
LATEST IN TRULANCE
1969 alumnus’ journey to CEO of Synergy Pharmaceuticals, FDA-approved drug TRULANCE starts with UMSL chemistry degree
Gary Jacob’s rise to CEO of a Nasdaq-listed biotech company started with chemistry classes in Benton Hall and a willingness to take risks and embrace change.
1969 alumnus’ journey to CEO of Synergy Pharmaceuticals, FDA-approved drug TRULANCE starts with UMSL chemistry degree
Gary Jacob’s rise to CEO of a Nasdaq-listed biotech company started with chemistry classes in Benton Hall and a willingness to take risks and embrace change.
Eye on UMSL: Lifting his voice
Connor Mullenschlader was among the more than 15 vocal studies students performing in an end-of-the-semester recital last week.
MORE IN TRULANCE
LATEST NEWS
- Eye on UMSL: Lifting his voice
- UMSL Entrepreneurship and Innovation Center welcomes newest Anchor Accelerator cohort
- UMSL biology students assembling Osage Orange genome as part of American Campus Tree Genomes initiative
- New research from Anne Austin reveals prevalence of tattooing in ancient Nubia, including on young children
- Army ROTC returns to UMSL campus
- UMSL Tritons weekly rewind
- UMSL set to celebrate nearly 900 new graduates during fall commencement ceremonies
- Jadyn Mullen lands position as labor and delivery nurse at Barnes-Jewish Hospital
- Missouri Optometry Hall of Fame opens inside UMSL College of Optometry
- Accounting graduate Alex Paubel adds new layers to Paubel family legacy at UMSL
